Is Procalcitonin Biomarker-Guided Antibiotic Therapy a Cost-Effective Approach to Reduce Antibiotic Resistant and Clostridium difficile Infections in Hospitalized Patients?
2018 ◽
Vol 22
(9)
◽
pp. 616-625
◽
2019 ◽
Vol 114
(1)
◽
pp. S112-S113
Keyword(s):
2015 ◽
Vol 110
◽
pp. S559
2013 ◽
Vol 52
(2)
◽
pp. 671-673
◽
2003 ◽
Vol 2
(1)
◽
pp. 71-72
◽
Keyword(s):
Keyword(s):